Drugs.com
@drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA approves new warning for Depo-Provera birth control shot regarding meningioma (brain tumor) risk. Used by ~25% of sexually active U.S. women. Pfizer faces 1,000+ lawsuits. Talk to your healthcare provider about options. #DepoProvera www.drugs.com/news/fda-add...
FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot - Drugs.com MedNews
THURSDAY, Dec. 18, 2025 (HealthDay News The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control
www.drugs.com
December 18, 2025 at 5:58 PM
FDA approves new warning for Depo-Provera birth control shot regarding meningioma (brain tumor) risk. Used by ~25% of sexually active U.S. women. Pfizer faces 1,000+ lawsuits. Talk to your healthcare provider about options. #DepoProvera www.drugs.com/news/fda-add...
New clinical trial: #LipoicAcid supplement may slow brain atrophy in progressive MS patients, though it didn't improve walking speed. MRI scans showed promising results. Researchers suggest better delivery methods could unlock this antioxidant's potential for MS. www.drugs.com/news/over-co...
Over-The-Counter Supplement, Lipoic Acid, Might Help Multiple Sclerosis Treatment - Drugs.com MedNews
WEDNESDAY, Dec. 17, 2025 An over-the-counter supplement called lipoic acid might help slow the loss of gray matter in the brains of people with progressive mult
www.drugs.com
December 17, 2025 at 6:12 PM
New clinical trial: #LipoicAcid supplement may slow brain atrophy in progressive MS patients, though it didn't improve walking speed. MRI scans showed promising results. Researchers suggest better delivery methods could unlock this antioxidant's potential for MS. www.drugs.com/news/over-co...
New JAMA review challenges #MedicalMarijuana hype: 15 years of research shows weak evidence for most uses, like pain and sleep. 30% of users may face addiction risk. Few FDA-approved cannabinoids exist, but most dispensary products lack scientific backing.
Large Review Finds Limited Proof Behind Many Medical Cannabis Uses - Drugs.com MedNews
MONDAY, Dec. 15, 2025 Medical marijuana is often seen as a safer, natural way to ease pain, anxiety or sleep issues. But a large new review suggests that for ma
www.drugs.com
December 15, 2025 at 6:04 PM
New JAMA review challenges #MedicalMarijuana hype: 15 years of research shows weak evidence for most uses, like pain and sleep. 30% of users may face addiction risk. Few FDA-approved cannabinoids exist, but most dispensary products lack scientific backing.
Melanoma breakthrough: Lower immunotherapy doses = better results! New study shows "flipped dose" treatment with #nivolumab/ipilimumab improved survival (42 vs 14 months) with fewer side effects. Sometimes, less is more in cancer treatment. www.drugs.com/news/less-mo...
Less Is More For Melanoma-Fighting Immunotherapy, Nivolumab/Ipilimumab, Study Argues - Drugs.com MedNews
FRIDAY, Dec. 12, 2025 Less might be more when it comes to immunotherapy treatment of melanoma, a new study says. Lower doses of a drug used to treat melanoma ca
www.drugs.com
December 12, 2025 at 6:13 PM
Melanoma breakthrough: Lower immunotherapy doses = better results! New study shows "flipped dose" treatment with #nivolumab/ipilimumab improved survival (42 vs 14 months) with fewer side effects. Sometimes, less is more in cancer treatment. www.drugs.com/news/less-mo...
FDA reviewing two infant RSV medicines, Beyfortus and Enflonsia, despite no reported safety problems. Drugmakers cite strong safety records, with Beyfortus given to 6M+ babies globally. Review comes amid increased scrutiny of immunizations. #RSVMedications www.drugs.com/news/fda-rev...
FDA Reviewing RSV Drugs, Beyfortus and Enflonsia for Infants, Though No Safety Issues Found - Drugs.com MedNews
THURSDAY, Dec. 11, 2025 Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been rep
www.drugs.com
December 11, 2025 at 5:53 PM
FDA reviewing two infant RSV medicines, Beyfortus and Enflonsia, despite no reported safety problems. Drugmakers cite strong safety records, with Beyfortus given to 6M+ babies globally. Review comes amid increased scrutiny of immunizations. #RSVMedications www.drugs.com/news/fda-rev...
New study: GLP-1 drugs like Ozempic don't appear to lower cancer risk as hoped, but they don't increase it either. Researchers followed 94,000+ adults for 70 weeks. Experts say longer studies are needed since cancers develop slowly. #GLP1CancerRisk www.drugs.com/news/glp-1-s...
GLP-1 Medications, Such as Ozempic, Zepbound, Show Little Effect on Cancer, Study Shows - Drugs.com MedNews
WEDNESDAY, Dec. 10, 2025 A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped. Researchers analyzed
www.drugs.com
December 10, 2025 at 6:31 PM
New study: GLP-1 drugs like Ozempic don't appear to lower cancer risk as hoped, but they don't increase it either. Researchers followed 94,000+ adults for 70 weeks. Experts say longer studies are needed since cancers develop slowly. #GLP1CancerRisk www.drugs.com/news/glp-1-s...
NEW STUDY: Vitamin K refusal for newborns doubled to 5% by 2024. It's NOT a vaccine—it's a one-time shot preventing deadly bleeding and brain damage. Without it, babies face 80x higher bleeding risk. Misinformation is putting 200K babies at risk annually.#VitaminK www.drugs.com/news/more-pa...
More Parents Refuse Vitamin K Shot for Newborns, Study Finds - Drugs.com MedNews
TUESDAY, Dec. 9, 2025 More parents are saying no to vitamin K shots for their newborns, and experts warn babies could be at serious risk.A study published Dec.
www.drugs.com
December 9, 2025 at 6:18 PM
NEW STUDY: Vitamin K refusal for newborns doubled to 5% by 2024. It's NOT a vaccine—it's a one-time shot preventing deadly bleeding and brain damage. Without it, babies face 80x higher bleeding risk. Misinformation is putting 200K babies at risk annually.#VitaminK www.drugs.com/news/more-pa...
New study: Over half of TikTok #epilepsy treatment videos contain false information, yet they're getting millions more views than doctor-created content. Misleading clickbait about unproven remedies vastly outperforms evidence-based advice. www.drugs.com/news/tiktok-...
TikTok Videos Mislead On Epilepsy Care, Experts Say - Drugs.com MedNews
MONDAY, Dec. 8, 2025 Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a new study says.
www.drugs.com
December 8, 2025 at 5:56 PM
New study: Over half of TikTok #epilepsy treatment videos contain false information, yet they're getting millions more views than doctor-created content. Misleading clickbait about unproven remedies vastly outperforms evidence-based advice. www.drugs.com/news/tiktok-...
Pediatric cancer survival rates have soared to 87%, up from 63% in the 1970s. Deaths have dropped 57% since 1970. Breakthrough treatments are saving thousands of young lives #CarTCellTherapyhttps://www.drugs.com/news/substantial-progress-made-against-childhood-cancers-report-says-127825.html
Substantial Progress Made Against Childhood Cancers, Report Says - Drugs.com MedNews
FRIDAY, Dec. 5, 2025 Leanna Munir was a 6-year-old bundle of energy two years ago, until one day her vim and vigor vanished without warning. I couldn t force he
www.drugs.com
December 5, 2025 at 7:31 PM
Pediatric cancer survival rates have soared to 87%, up from 63% in the 1970s. Deaths have dropped 57% since 1970. Breakthrough treatments are saving thousands of young lives #CarTCellTherapyhttps://www.drugs.com/news/substantial-progress-made-against-childhood-cancers-report-says-127825.html
#Kisqali extends survival by ~1 year for HR+/HER2- advanced breast cancer, with 5-year overall survival benefits. Maintains quality of life during treatment. Also significantly reduces recurrence in high-risk stage II-III early breast cancer. Consult your oncologist.
Does Kisqali improve survival / life expectancy for mBC?
Official answer: Kisqali can extend survival and the amount of time you live without HR+/HER2- advanced or metastatic breast cancer...
www.drugs.com
December 5, 2025 at 5:25 PM
#Kisqali extends survival by ~1 year for HR+/HER2- advanced breast cancer, with 5-year overall survival benefits. Maintains quality of life during treatment. Also significantly reduces recurrence in high-risk stage II-III early breast cancer. Consult your oncologist.
FDA alert: Some Abbott #FreeStyleLibre3 sensors may show incorrect blood sugar readings. Linked to 7 deaths, 700+ injuries globally. 3 million devices affected. False readings can lead to dangerous treatment decisions. www.drugs.com/news/million...
Millions of Abbott Glucose Sensors Recalled After Faulty Readings Linked to Deaths - Drugs.com MedNews
THURSDAY, Dec. 4, 2025 Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert from the U.S. Food and Drug Administratio
www.drugs.com
December 5, 2025 at 2:22 AM
FDA alert: Some Abbott #FreeStyleLibre3 sensors may show incorrect blood sugar readings. Linked to 7 deaths, 700+ injuries globally. 3 million devices affected. False readings can lead to dangerous treatment decisions. www.drugs.com/news/million...
CDC committee voting today on newborn hepatitis B vaccines, a decades-old practice that's reduced severe infections by 99%. Some question the timing, but new analysis of 400+ studies find no safety concerns, estimating 6M+ infections prevented. #HepBVaccine www.drugs.com/news/cdc-pan...
CDC Panel May Change Longtime Rule on Hepatitis B Shots for Newborns - Drugs.com MedNews
THURSDAY, Dec. 4, 2025 A U.S. Centers for Disease Control and Prevention (CDC) advisory group is meeting today and preparing to vote on whether newborns should
www.drugs.com
December 4, 2025 at 6:18 PM
CDC committee voting today on newborn hepatitis B vaccines, a decades-old practice that's reduced severe infections by 99%. Some question the timing, but new analysis of 400+ studies find no safety concerns, estimating 6M+ infections prevented. #HepBVaccine www.drugs.com/news/cdc-pan...
Rinvoq and Dupixent both treat atopic dermatitis but differ significantly. Rinvoq addresses rheumatoid arthritis, psoriatic arthritis, IBD, and more. Dupixent targets asthma, nasal polyps, eosinophilic esophagitis, and allergic conditions. #RinvoqVsDupixent
How do Rinvoq and Dupixent compare?
Official answer: Atopic dermatitis (eczema) is a challenging skin disease, and therapies have advanced with the development of targeted...
www.drugs.com
December 4, 2025 at 5:25 PM
Rinvoq and Dupixent both treat atopic dermatitis but differ significantly. Rinvoq addresses rheumatoid arthritis, psoriatic arthritis, IBD, and more. Dupixent targets asthma, nasal polyps, eosinophilic esophagitis, and allergic conditions. #RinvoqVsDupixent
New Stanford study shows shingles vaccine may protect brain health and reduce dementia risk. Among those with dementia, vaccination linked to lower mortality. Research on 282,500+ adults found 3.5% fewer diagnoses over 7 years. #ShinglesVaccineDementia www.drugs.com/news/shingle...
Shingles Vaccine May Help Slow Dementia, New Study Finds - Drugs.com MedNews
WEDNESDAY, Dec. 3, 2025 A routine shingles shot may do more than prevent a painful rash. It could also support long-term brain health, new research shows. In a
www.drugs.com
December 3, 2025 at 8:15 PM
New Stanford study shows shingles vaccine may protect brain health and reduce dementia risk. Among those with dementia, vaccination linked to lower mortality. Research on 282,500+ adults found 3.5% fewer diagnoses over 7 years. #ShinglesVaccineDementia www.drugs.com/news/shingle...
#AlzheimersDisease has no cure, but medications can temporarily slow cognitive decline. FDA-approved treatments include cholinesterase inhibitors, glutamate regulators, combination therapies, and newer monoclonal antibodies like Leqembi and Kisunla.
What are the current medications for Alzheimer's disease?
Official answer: As someone who has served as a caretaker for a family member with Alzheimer's disease, I know firsthand how...
www.drugs.com
December 3, 2025 at 5:25 PM
#AlzheimersDisease has no cure, but medications can temporarily slow cognitive decline. FDA-approved treatments include cholinesterase inhibitors, glutamate regulators, combination therapies, and newer monoclonal antibodies like Leqembi and Kisunla.
WHO's first-ever obesity treatment guidelines recognize it as a chronic disease affecting 1B+ people. GLP-1 medications can help, but require comprehensive care including nutrition, exercise, and behavioral support. #WHOObesityGuidelines www.drugs.com/news/issues-...
WHO Issues First Guidance on Using GLP-1 Drugs to Treat Obesity - Drugs.com MedNews
TUESDAY, Dec. 2, 2025 The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects
www.drugs.com
December 2, 2025 at 6:30 PM
WHO's first-ever obesity treatment guidelines recognize it as a chronic disease affecting 1B+ people. GLP-1 medications can help, but require comprehensive care including nutrition, exercise, and behavioral support. #WHOObesityGuidelines www.drugs.com/news/issues-...
#Kesimpta (ofatumumab) rapidly lowers B cells in MS patients. Clinical studies show 77-78% had B-cell levels drop below normal within one week of first injection, increasing to 95-96% by two weeks. Fast-acting disease management for multiple sclerosis.
How long does it take for Kesimpta to work?
Official answer: Kesimpta (ofatumumab) begins lowering B cells within one week of starting treatment. Clinical studies showed that...
www.drugs.com
December 2, 2025 at 5:25 PM
#Kesimpta (ofatumumab) rapidly lowers B cells in MS patients. Clinical studies show 77-78% had B-cell levels drop below normal within one week of first injection, increasing to 95-96% by two weeks. Fast-acting disease management for multiple sclerosis.
New trial: Injectable antibody #Tezspire helped 90% of severe asthma patients reduce daily steroids; half stopped completely. Two-thirds had no attacks. Benefits started within two weeks, offering hope beyond steroids' serious side effects. www.drugs.com/news/monthly...
Monthly Injection of Tezepelumab (Tezspire), Could Free People With Severe Asthma From Steroids - Drugs.com MedNews
MONDAY, Dec. 1, 2025 People with severe asthma often take daily steroid medications to help prevent attacks, yet the drugs can bring about serious side effects.
www.drugs.com
December 1, 2025 at 7:09 PM
New trial: Injectable antibody #Tezspire helped 90% of severe asthma patients reduce daily steroids; half stopped completely. Two-thirds had no attacks. Benefits started within two weeks, offering hope beyond steroids' serious side effects. www.drugs.com/news/monthly...
#NurtecODT treats and prevents episodic migraines in adults. Available as orally disintegrating tablets (75mg) placed on or under the tongue, dissolving without liquid. For acute migraines, take one tablet when symptoms start; maximum 75mg per 24 hours.
Nurtec ODT Patient Tips: 7 things you should know
Easy-to-read patient tips for Nurtec ODT covering how it works, benefits, risks, and best practices.
www.drugs.com
December 1, 2025 at 5:25 PM
#NurtecODT treats and prevents episodic migraines in adults. Available as orally disintegrating tablets (75mg) placed on or under the tongue, dissolving without liquid. For acute migraines, take one tablet when symptoms start; maximum 75mg per 24 hours.
#Imfinzi (durvalumab) treats multiple cancers by blocking PD-L1, preventing cancer cells from deactivating immune T-cells. This immune checkpoint inhibitor boosts the body's natural cancer-fighting response for lung, liver, biliary, endometrial, and bladder cancers.
What type of drug is Imfinzi?
Official answer: Imfinzi (durvalumab) is a programmed death-ligand 1 (PD-L1) blocking antibody (also called an immune checkpoint...
www.drugs.com
November 28, 2025 at 5:25 PM
#Imfinzi (durvalumab) treats multiple cancers by blocking PD-L1, preventing cancer cells from deactivating immune T-cells. This immune checkpoint inhibitor boosts the body's natural cancer-fighting response for lung, liver, biliary, endometrial, and bladder cancers.
#JAKInhibitors block immune signals causing inflammation in rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. Available orally or topically, they're DMARDs that slow joint damage. Xeljanz was the first FDA-approved JAK inhibitor in 2012.
What are JAK inhibitors and how do they work?
Official answer: Janus kinase (JAK) inhibitors are a group of medicines that help block immune system signals in the body that can lead...
www.drugs.com
November 27, 2025 at 5:25 PM
#JAKInhibitors block immune signals causing inflammation in rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. Available orally or topically, they're DMARDs that slow joint damage. Xeljanz was the first FDA-approved JAK inhibitor in 2012.
Half of suicide deaths show no prior warning signs. University of Utah researchers found these individuals have fewer mental health diagnoses and different risk factors. Current screening may miss them. Alternative indicators may include chronic pain and inflammation. www.drugs.com/news/some-su...
Some Suicide Victims Show No Typical Warning Signs, Study Finds - Drugs.com MedNews
WEDNESDAY, Nov. 26, 2025 For many families who lose someone to suicide, the same question comes up again and again How did we not see this coming A new study su
www.drugs.com
November 26, 2025 at 9:52 PM
Half of suicide deaths show no prior warning signs. University of Utah researchers found these individuals have fewer mental health diagnoses and different risk factors. Current screening may miss them. Alternative indicators may include chronic pain and inflammation. www.drugs.com/news/some-su...
Lyrica (pregabalin) and gabapentin treat epilepsy and nerve pain, but aren't interchangeable. Lyrica works faster (peak in 1 hour vs 3-4 hours) with different side effects and uses. Both are gabapentinoids but require doctor guidance when switching. #LyricaVsGabapentin
Lyrica vs Gabapentin: What's the difference?
Official answer: Both Lyrica and gabapentin are used as anti-epileptic medications and to treat nerve pain. But there are several...
www.drugs.com
November 26, 2025 at 5:25 PM
Lyrica (pregabalin) and gabapentin treat epilepsy and nerve pain, but aren't interchangeable. Lyrica works faster (peak in 1 hour vs 3-4 hours) with different side effects and uses. Both are gabapentinoids but require doctor guidance when switching. #LyricaVsGabapentin
Novo Nordisk's oral semaglutide (Ozempic/Wegovy ingredient) failed to slow Alzheimer's disease in trials with 3,800+ patients. Though safe, it didn't prevent cognitive decline versus placebo. #SemaglutideAlzheimersDisease www.drugs.com/news/pill-se...
Pill Form of Semaglutide Fails to Slow Alzheimer's in Large Trial - Drugs.com MedNews
TUESDAY, Nov. 25, 2025 A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer s disease, drugmaker Novo Nor
www.drugs.com
November 25, 2025 at 6:15 PM
Novo Nordisk's oral semaglutide (Ozempic/Wegovy ingredient) failed to slow Alzheimer's disease in trials with 3,800+ patients. Though safe, it didn't prevent cognitive decline versus placebo. #SemaglutideAlzheimersDisease www.drugs.com/news/pill-se...
Migraines affect 1 in 7 U.S. adults, causing severe pain, nausea, and light sensitivity due to brain activity and blood vessel changes. Unlike typical headaches, they're a leading disability cause. Manage head pain effectively. #MigraineVsHeadache
Migraine vs Headache: How to tell the difference?
Official answer: A migraine is a type of headache caused by changes in brain activity and blood vessels, while a typical headache is...
www.drugs.com
November 25, 2025 at 5:25 PM
Migraines affect 1 in 7 U.S. adults, causing severe pain, nausea, and light sensitivity due to brain activity and blood vessel changes. Unlike typical headaches, they're a leading disability cause. Manage head pain effectively. #MigraineVsHeadache